Mocchetti I, Schwartz J P, Costa E
Mol Pharmacol. 1985 Jul;28(1):86-91.
The repeated administration of haloperidol or fenfluramine for several days led to an increase of enkephalin content in specific brain areas. In order to characterize the nature of the dynamic changes underlying this increase, we measured the content of proenkephalin mRNA (PE-mRNA), of high molecular weight (HMW) enkephalin precursors, and of low molecular weight enkephalin peptides (LMW) in various brain areas. To measure PE-mRNA, we hybridized the specific mRNA with a [32P]cDNA probe for human pheochromocytoma PE. HMW and LMW enkephalin content was measured by radioimmunoassay after separation of the immunoreactive peaks by Bio-Gel P-2 column chromatography and enzymatic digestion of the precursors. Haloperidol treatment increased enkephalins, the precursor, and PE-mRNA content in the striatum, suggesting that this drug might increase enkephalin steady state by increasing transcription, translation, or both processes. In contrast, fenfluramine increased hypothalamic and striatal enkephalin content by preferentially reducing neuropeptide utilization or decreasing its catabolism without changing its synthesis.
连续数天给予氟哌啶醇或芬氟拉明会导致特定脑区脑啡肽含量增加。为了明确这种增加背后动态变化的本质,我们测量了不同脑区中前脑啡肽原mRNA(PE-mRNA)、高分子量(HMW)脑啡肽前体以及低分子量脑啡肽肽(LMW)的含量。为了测量PE-mRNA,我们将特异性mRNA与针对人嗜铬细胞瘤PE的[32P]cDNA探针进行杂交。通过Bio-Gel P-2柱色谱分离免疫反应峰并对前体进行酶消化后,采用放射免疫分析法测量HMW和LMW脑啡肽含量。氟哌啶醇治疗可增加纹状体中脑啡肽、前体和PE-mRNA的含量,这表明该药物可能通过增加转录、翻译或这两个过程来提高脑啡肽的稳态水平。相比之下,芬氟拉明通过优先减少神经肽的利用或降低其分解代谢而不改变其合成,从而增加下丘脑和纹状体中的脑啡肽含量。